In our study, we screened out five pseudogenes (ANXA2P2, EEF1A1P9, FER1L4, HILS1, and RAET1K) that were differentially expressed between LGG and GBM and were associated with the prognosis of glioma patients. This evidence concerns the gene RAET1K and central nervous system cancer.